According to Insmed's latest financial reports the company's current EPS (TTM) is -$6.92. In 2022 the company made an earnings per share (EPS) of -$5.12 a decrease over its 2021 EPS that were of -$5.08.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$7.11 | 38.86% |
2022 | -$5.12 | 0.78% |
2021 | -$5.08 | 28.57% |
2020 | -$3.95 | -0.99% |
2019 | -$3.99 | -27.96% |
2018 | -$5.54 | 47.55% |
2017 | -$3.75 | 0.7% |
2016 | -$3.73 | 39.9% |
2015 | -$2.66 | 9.73% |
2014 | -$2.43 | 17.09% |
2013 | -$2.07 | 0.64% |
2012 | -$2.06 | -46.42% |
2011 | -$3.84 | 497.96% |
2010 | -$0.64 | -105.1% |
2009 | $12.61 | -850.78% |
2008 | -$1.68 | -24.71% |
2007 | -$2.23 | -71.67% |
2006 | -$7.87 | -28.57% |
2005 | -$11.02 | 23.53% |
2004 | -$8.92 | 134.48% |
2003 | -$3.81 | -73.64% |
2002 | -$14.43 | -2.65% |
2001 | -$14.83 | -86.64% |
2000 | -$111.02 |